Mid-America Isotopes

Mid-America Isotopes is a specialized nuclear pharmacy based in Ashland, Missouri, that provides radiopharmaceuticals and nuclear medicine services to healthcare providers. Founded in 1990, the company specializes in the compounding and distribution of diagnostic and therapeutic radioactive drugs used in medical imaging procedures such as PET and SPECT scans. In 2016, the company was acquired by PharmaLogic Holdings, integrating it into a larger North American network of radiopharmacies. Mid-America Isotopes also maintains a close relationship with the University of Missouri through its involvement in Essential Isotopes, a partnership focused on PET radiopharmaceutical production.